VELAN CAPITAL, L.P. purchased 0.9% of their position (72.02K shares) of PROGENICS PHARMACEUTICALS INC on the open market
Open‑market purchase worth $359.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/11/2019ACC: 0000921895-19-002393
10% OwnerOther
Since Aug 2019
+72.02K
Net shares
Net buyer
$359.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
72.02K acquired
Non-Derivative Transactions1
Common Stock, $0.0013 par value
Direct
Shares
+72.02K
Price / share
$4.99
Trade value
$359.73K
% of position
0.9%
9/9/2019
7.94M→8.01M
Total
Net shares
+72.02K
Net value
$359.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0013 par value Direct | 9/9/2019 | P · Purchase | +72.02K | $4.99 | $359.73K | 0.9% | 7.94M | 8.01M |
| Total | +72.02K | $359.73K | ||||||
Derivative Transactions0
No derivative transactions reported